HIM
BSX icon

Hanlon Investment Management’s Boston Scientific BSX Stock Holding History

Hanlon Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-210,343
Closed -$4.92M – 57
2016
Q2 		$4.92M Buy
+210,343
New +$4.55M 0.43% 47
2016
Q1 		– Sell
-207,270
Closed -$3.82M – 80
2015
Q4 		$3.82M Buy
+207,270
New +$3.71M 0.36% 62

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Hanlon Investment Management's BSX Position: Q3 2016 in Review

Hanlon Investment Management sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 210,343 shares — an estimated $4.92M sold.

Hanlon Investment Management first reported a position in BSX in Q4 2015 and held it in 2 quarters. The position peaked at $4.92M in Q2 2016. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Hanlon Investment Management reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Hanlon Investment Management sold 210,343 Boston Scientific shares in Q3 2016, an estimated $4.92M.
  • Hanlon Investment Management first reported a position in Boston Scientific in Q4 2015 and held it in 2 quarters.
  • Hanlon Investment Management's Boston Scientific position peaked at $4.92M in Q2 2016.
  • 568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Hanlon Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.